Health Archive » January, 2025

Health - January, 2025

410 articles

• New York Scores Win In Reproductive Rights Labor Law Suit
• Pharmacy Escapes Novo Nordisk's Suit Over Ozempic
• Funding Freezes 'Commonplace,' Feds Tell DC Judge
• Express Scripts Says FTC Tried To Swamp It With Lawsuits
• Med Transport Broker Must Face Injury Claims, Ga. Panel Says
• 3rd Circ. Backs DOL's $7M Win In Care Co. Wage Suit
• 6 Argument Sessions Benefits Attys Should Watch In Feb.
• NY Doctor Charged In La. For Prescribing Abortion Pill Online
• Supreme Court Eyes Its 'Next Frontier' In FCC Delegation Case
• Owners Appeal Docs Order In Yale's $435M Hospital Sale Fight
• After High Court, SuperValu's $123M FCA Case Heads To Trial
• Litigation Funding Disclosure Debate: Strategy Considerations
• Off The Bench: NIL Deal Skeptics, Padres Feud, Rozier Probe
• Judge Grants Fraud Retrial After Witness 'Forgot to Shut Up'
• Ga. Appeals Court Backs Wellstar In Doc Defamation Fight
• Investors Say Walgreens Misled Over Prescription Misuse
• Chiropractors Can Testify On Injury Cause, Mich. Panel Says
• Law360 Seeks Members For Its 2025 Editorial Boards
• Trump Funding Freeze Blocked As Court Doubts Reversal
• 2025 May Be A Breakout Year For The Cannabis Industry
• Appeal On Tap As Judge OKs Mich. Conversion Therapy Ban
• JAMS Adds AI-Focused Litigation Vet To Arbitration Team
• RFK Jr. Says He'll Give Stake In Merck Vaccine Case To Son
• Seasoned Patterson Belknap Trial Team Joins Linklaters In NY
• Taxation With Representation: Cravath, Gibson Dunn, Milbank
• FDA's Red No. 3 Ban Reshapes Food Safety Legal Landscape
• 4 Firms Guide Pair Of Biotech IPOs Raising $415M Combined
• Merck Can't Ditch Worker's Race Bias Suit Ahead Of Trial
• 2nd Circ. Sees No Skadden Conflict In Pharma Merger Work
• Patient Transportation Co. Hid Cash Flow Woes, Investor Says
• CMS Fine To Limit $41M Deal Talks To Lowest-Priced Bidders
• Supreme Court Urged To Clarify Alice, End 1-Line Orders
• Wash. Court Rejects Palestinian Patient's Verdict Bias Appeal
• Former Pharma Exec Gets 2 Months For Insider Trading
• Ga. Businesses 'Over The Moon' With Tort Reform Proposals
• Mich. Judge Says 'Dial It Down' As Insults Fly In DQ Hearing
• DOJ Calls UnitedHealth Dismissal Bid A Discovery 'End Run'
• Scope And Nature Of Judicial Relief Will Affect Loper's Impact
• Samsung Gets PTAB To Review 2 Smart Ring Patents
• RFK Blasts Industry 'Puppets' Amid HHS Nomination Fight
• The Implications Of E-Cigarette Cos. Taking Suits To 5th Circ.
• Adventure Photography Makes Me A Better Lawyer
• How Views On Healthcare Price Transparency Are Changing
• MoFo Guides Welltower's $900M Senior Living REIT Deal
• Beasley Firm Must Face Ex-Client's Suit Over Med Mal Claim
• NC Biz Court Bulletin: Sanctions Miss, Philip Morris Refund
• Rumors Fly As Trump Seeks Deal To Keep TikTok Alive
• Pa. Pot Panels Not 'Arbitrary' In Assigning Different Scores
• Cooley, Latham Steer Beta Bionics' Upsized $204M IPO
• Albertsons Must Face County's Opioid Nuisance Claims
• Court Garbled Pharma Owner's Fraud Charges, 6th Circ. Told
• Workers Allege Anti-Indian Bias At Ga. Health Systems
• Allstate Says Houston Referral Site Ran Kickback Scheme
• Lab Co-Owner Gets 9 Years For $369M COVID Testing Scheme
• Navigating The Potential End Of GLP-1 Drug Shortages
• 9th Circ. Affirms Ax Of Patent Atty's Allergan FCA Fight
• 4 Questions About Trump's Federal Worker Resignation Policy
• High Court Could Further Limit Deference With TCPA Fax Case
• Politicized OIGs Could Target Federal Employees, Contractors
• Firm Sued Over Ex-Eagles Player's $43.5M Knee Injury Verdict
• 5 Ways To Create Effective Mock Assignments For Associates
• Atty's Indictment DQs Firm From Retaliation Suit, Panel Told
• Jurors Find Fund Can Keep $11M From Short-Swing Trades
• CFPB Cheers On State Bids To Restrict Medical Debt Reporting
• Texas Cardiology Practice Beats Monopolization Suit
• Tribal Leaders Call Funding Freeze A 'Step In Wrong Direction'
• KKR Plugs $250M Into Healthcare Biz Henry Schein
• White House Rescinds Trump's Spending Freeze
• RFK Jr. Disputes Anti-Vax Label In HHS Confirmation Hearing
• Trump Targets Gender-Affirming Care For Minors In New Order
• 4th Circ. Raises Questions Over Health Data Access Order
• Intuitive Beats $140M Antitrust Case Ahead Of Closings
• Minn. AG Settles Novo Nordisk Insulin Claims With Price Cap
• Cigna Can't Escape Fight Over Prosthetic Coverage In Maine
• Allegheny Health Network Hit With Data Breach Claims
• Drugs Made In America SPAC Nets $200M To Buy Pharma Biz
• Questions To Watch For In RFK Jr.'s Confirmation Hearing
• Feds Say Health System Can't Ditch Fraud Suit Over Surgeries
• Bain Capital Seeks Surgery Partners Buyout At $3.3B Value
• North Carolina Drug Testing Lab Inks $850K False Billing Deal
• Yale Unit Wants To Yank Hospital Sale Suit From Ch. 11 Court
• Texas Panel Wipes Baylor's $12M COVID Insurance Verdict
• Takeaways From DOJ Fraud Section's 2024 Year In Review
• Judge Temporarily Halts Trump's Funding Freeze
• IVF Suits Highlight Need For Better Legal Frameworks
• 4 Firms Look To Build $1B Sale Of Evergreen Theragnostics
• UnitedHealth Raises Cyberattack Estimate To 190M Individuals
• Takeda Pushes Meijer Antitrust Suit Into Arbitration
• Jury Will Decide $140M Intuitive Robo-Surgery Antitrust Case
• FOIA Lawsuit Seeks Marijuana Docs From Health Officials
• VA To Nix $6.1M In Contracts Under Trump's DEI Order
• 3rd Circ. Says Class Cert. Won't Work In Junk Fax Suit
• Fill-In Nurses, Staffing Agency Strike Deal To End Wage Suit
• Ind. Gov. Orders Analysis Of Nonprofit Hospitals' Tax Breaks
• Mich. Justices Strip Eye Doc's Fee Award In Noncompete Row
• Recent Suits Show Antitrust Agencies' Focus On HSR Review
• PureHealth Nabs Majority Stake In HHG In $2.3B Deal
• Cencora CLO's Pay Package Nearly Doubled In 2024
• Suit Over Gender Dysphoria Rule Frozen After Trump Order
• Trump Revives Federal Anti-Abortion Policies
• Intuitive Doesn't Owe 'Free-Riding' Firm $140M, Expert Says
• Pfizer To Pay $59M Over Unit's Migraine Drug Kickbacks
• BCBS Has 'High Hurdle' For New $13M Trial, Mich. Judge Says
• Justices To Clarify Article III Standing For Certified Classes
• Patient Can't Sue Over Clinic's 'Data Incident,' Ill. Justices Say
• Ill. Justices OK Workers' Injury Suits Over Dormant Diseases
• Anti-Abortion Group Seeks High Court Review Of NJ Probe
• J&J Escapes Part Of Worker's Drug Benefits Suit, For Now
• IVF Patients Want CooperSurgical Embryo Loss Suits Joined
• Feds Drop HIPAA Charges Against Houston Surgeon
• Trump Fires Inspectors General Without Notice
• 3rd Circ. Halts Pa. Med Insurer Suit Pending High Court Review
• Employer Groups Back Tossing Pension Annuity Suit In NY
• 5th Circ. Upholds Tossing Medicare Rate Policy Challenge
• Class Actions At The Circuit Courts: Nov. And Dec. Lessons
• NC Gov. GC's Bio Boasts BigTech Battles, Merger Dustup
• Greenberg Traurig Health Ace Joins Polsinelli In LA
• Mentorship Resolutions For The New Year
• Dentons Adds 2 Healthcare Attys From Katten In NY
• Venture-Backed IPO Recovery Could Be Muted, Report Says
• Intuitive Judge Walks Back 'Inappropriate' Witness Instruction
• Marlboro Smoker Was Target Of Deception, Jury Hears
• 4th Circ. Reads Kickback Law Broadly In Loss For Big Pharma
• GoodRx, PBMs Sued Over Alleged Generics Price-Fix Scheme
• Conn. High Court Snapshot: Atty's Bonus, Burn Verdict
• Retired Pittsburgh Cops Overpaid For Healthcare, Panel Rules
• Georgia Pain Doctor To Pay Feds $3.5M In FCA Settlement
• McKinsey Not Covered For Over 260 Opioid Suits, Chubb Says
• Conn. Lawmakers Target Healthcare After Hospital's Ch. 11
• YWCA's Standing Probed In Medicaid Abortion Fight
• Home Health Agency Operator Gets 12 Years For $100M Fraud
• Takeaways From FDA's Updated Confirmatory Trial Guidance
• Hillrom Rival Must Turn Over Antitrust Litigation Funding Docs
• Federal Agencies Must Order Full Return To Office By Friday
• Detainees' COVID Claims Blunted By ICE Action, Judge Hints
• DOJ Says Rule Expanding ACA To Dreamers Is On Solid Ground
• White And Williams' NY Office Head Named Bankruptcy Chair
• The Most Important Schedule I Drug Regulatory Shifts Of 2024
• UPS Penalty Demonstrates Goodwill Impairment Red Flags
• 15 States Reach $7.4B Settlement With Sackler Family
• Coaching Little League Makes Me A Better Lawyer
• 10th Circ. Affirms Toss Of Surgical Assistants' Antitrust Suit
• Fla. Court Proposes $19M In Damages In Spinal Products Suit
• RFK Filings Show Biopharma Stakes, Millions In Firm Income
• Maryland Gov. Taps NY Official As New Cannabis Head
• Med Mal Experts Need Only 1 Specialty, NJ Justices Rule
• Prospect Seeks To Move Conn. Hospital Sale Suit To Texas
• Pa. Justices Revive Case Over Hospital Care Discontinuation
• Wash. City Beats Fired Workers' Suit Targeting Vax Mandate
• Feds Trim Spine-Implant Kickback Case Ahead Of Trial
• 9th Circ. Won't Revive Express Scripts Generics Dispute
• Courts Must Stick To The Science On Digital Addiction Claims
• 5 Litigation Funding Trends To Note In 2025
• Unum Unlawfully Cut Disability, Hughes Hubbard Worker Says
• Paul Weiss Guides Ares On $304M Form Technologies Buy
• Mounting Pressure For PE Exits To Drive IPO Volume In 2025
• Minn. Senate Bill Seeks Income Tax Break For Med Costs
• Key Justices Stay Quiet As High Court Weighs FCC Deference
• Intuitive Seeks Midtrial End To Robo-Surgery Antitrust Suit
• The Legal And Practical Questions Around Trump's WHO Exit
• 4th Circ. Won't Undo Doctor's Conviction For Reusing Devices
• FDA Says 3 States' Mifepristone Suit Can't Be In Texas
• Trump Taps Pot Legalization Opponent As Acting DEA Head
• Calif. Appeals Court Reinstates Nurses' Wage Suit
• Union Worker Says He Has Standing To Sue Carpenters Plans
• WWE Accuser Eyes Deal With Doctor In Medical Records Feud
• FTC Privacy Enforcement Takeaways From 2024
• Firm Slams Beasley Allen's Bid To Nix Suit Over Talc Team-Up
• Advocates Vow Suits Over Trump Orders On LGBTQ+ Rights
• Law360 Names Practice Groups Of The Year
• Law360 Names Firms Of The Year
• Trump, Musk Sued By Nonprofits Over DOGE Transparency
• Ill. Court Upholds $6M Award In Fatal Opioid Overdose Suit
• Unified Care Services To Pay $18M To Settle PPP Case
• Walgreens Knowingly Filled Invalid Prescriptions, Feds Say
• Bayer, J&J Minimized Drug Reaction Data, 3rd Circ. Told
• MultiPlan Wants Antitrust Claims Over Pricing Tools Tossed
• Up Next At High Court: Forum Shopping & TCPA Definitions
• Walgreens Can't Hold Great-Grandson To Decade-Old TM Deal
• PE Firm Resolves FTC's Antitrust Anesthesia Roll-Up Case
• DEA Judge Kicks Pot Rescheduling Back To Administrator
• Trade Group Sues To Stop Federal Mental Health Parity Regs
• Hospice Compliance Program Uses Faulty Data, Providers Say
• 3rd Circ. Vexed By Remedies For Defunct Vax Mandate
• DOL Says Mental Health Parity Law Compliance Still Lacking
• Ex-Conn. State Employee Accused In $1.9M Medicaid Scam
• Rethinking Litigation Risk And What It Really Means To Win
• Duke U. Strikes Deal In Female Scientist's Pay Bias Suit
• 4 Battles Over Gender-Affirming Care To Watch In 2025
• Minn. Senate Bill Would Repeal Healthcare Provider Taxes
• Taxation With Representation: Simpson Thacher, Covington
• Issues To Watch In 2025's ERISA Litigation Landscape
• UK Litigation Roundup: Here's What You Missed In London
• Texas Judge Says 3 States Can Pursue Mifepristone Suit
• EpiPen Direct Buyers, Mylan Ink $75M Antitrust Deal
• NC Gov. Boosts Abortion Safeguards Amid 'Alarming Attacks'
• How DOGE's Bite Can Live Up To Its Bark
• Initial Green Light Given to UnitedHealth's Deal In TCPA Suit
• 2024 Was A Significant Year For HIPAA Compliance
• Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case
• NC Biz Court Bulletin: Judge Bids Adieu, TikTok Wants Out
• 5 Notable Information Security Events In 2024
• Chamber Slams Opioid Judge's PBM Audit Privilege Ruling
• Trinity Health, ER Nurses Seek OK For $450K Meal Break Deal
• Defense Fights Privilege Waiver In $250M COVID Fraud Case
• NYC Hospital Contractor To Pay $1.8M To End Wage Suit
• Henry Ford Patient Drops Data-Scraping Claims
• Playing Rugby Makes Me A Better Lawyer
• Gilead, Feds Resolve HIV Drug Patent Dispute Amid Appeal
• FTC Won't Disqualify Commissioners From PBM Insulin Case
• SEC Dings Pharma Co., Ex-CFO Over Prescription Scheme
• Ruling On Fla. Gender Law Animus Is Flawed, 11th Circ. Told
• Dem AGs Want In On Case Challenging 'Dreamers' Healthcare
• Justices Asked If Zoning Immunity Can Pass To Private Entity
• 9th Circ. Eyes Undoing Trans Patients' Win In ACA Bias Suit
• DOJ Reports $2.9B Haul Under FCA, Largest In 3 Years
• 3rd Circ. Preview: NFL Concussion Benefits Fight Tops January
• How 2025 NDAA May Affect DOD Procurement Protests
• Looking Back At 2024's Noteworthy State AG Litigation
• Pa. Malpractice Fund Can't Get Second Chance At 3rd Circ.
• Judge Warns DOJ: Settle Burger Forfeiture Suit Or Pay Up
• Former FDA Official Joins King & Spalding Life Sciences Team
• No, Litigation Funders Are Not 'Fleeing' The District Of Del.
• Holland & Knight Adds Ex-GOP Rep. To Policy Advisory Team
• Atrium Health Accused Of Giving Patient Data To Google
• Podcaster Must Face Discovery In ICE Doctor's Defamation Row
• New EMTALA Suit in Idaho Seeks To Keep Injunction
• Latham Grabs Top Spot For 2024 IPOs By Large Margin
• DOJ Says Software Co.'s $12.7M Copyright Win Is Sufficient
• Fla. Panel Told Law Precludes Damages For Smoker's Heir
• Cannabis Reformers Split After DEA Judge Cancels Hearings
• Prospect Medical Beats Objection To $29M In Ch. 11 Funds
• Dispute Over Eli Lilly Weight Loss Drug Reignited
• Conn. Justices Revive Insemination Suit, Punt On 'Wrongful Life'
• Liability Risk For AI In Medical Devices Demands Greater Care
• Top 10 Noncompete Developments Of 2024
• FTC Issues Second Report On PBMs, Expanding Study Scope
• Leaked Deals Achieved Higher Premiums But Little Else
• Insurer Says It Owes No Coverage In Pot Co. Death Suit
• 5 E-Discovery Predictions For 2025 And Beyond
• Both Michigan US Attys Resign Ahead Of Inauguration
• MedQuest Adds Health System In-House Vet As Top Atty
• Eli Lilly Says Colo. Clinic Selling Deceptive Weight Loss Drug
• 2nd Circ. Rules Prison Docs Can't Escape Indifference Claims
• Mass. AG Says Insulin Makers, Middlemen Colluded On Costs
• Robo-Surgery Part Reset Is Reliable, Expert Tells Antitrust Jury
• Texas Judge Urged To Halt CFPB Medical Debt Reporting Rule
• Lincare Pays $1.15M To End Wash. Medicaid Fraud Probe
• Amid Claims Of Agency Bias, DEA Judge Nixes Pot Hearings
• California's AG Warns Businesses State Is Not AI 'Wild West'
• Blue Cross Can't Skirt NC Hospital's Defamation Claims
• Ozempic Maker Says Atlanta Clinic Misuses TM To Sell Meds
• What 2024 Tells Us About Calif. Health Transaction Reviews
• RFK Jr.'s Wash. Anti-Vax Suit Can't Get High Court Save
• 5 Firms Steer Up-To-$750M Sale Of Life Molecular Imaging
• Lilly To Buy Scorpion Cancer Program For Up To $2.5B
• Republican Trifecta Amplifies Risks For Cos. In 3 Key Areas
• Cannabis Co. Again Seeks Dismissal Of Finder's Fee Suit
• Proskauer Faces Revived DQ Bid In NJ Hospital Antitrust Fight
• $13.4M Suit Against Insurer For Conn. Death Verdict Paused
• PBMs' Federal Work Irrelevant To Opioid Suit, Mich. AG Says
• Ex-Benefytt Affiliate Violated Consumer Laws, Suit Says
• Cravath-Led J&J Paying $14.6B For Neuropsychiatric Drug Co.
• Feds Say NC Medical Biz Owner Overbilled For Nutrient Drinks
• Nvidia's Healthcare Ambitions Grow In New Partnerships
• Hospital Operator Hits Ch. 11 With $1B-Plus Debt, Sale Plans
• Intuitive Rips VP's Credibility In Robo-Surgery Antitrust Trial
• Masimo, Apple Fight Over Watch IP In Post-Bench Trial Briefs
• Infosys Files Antitrust Counterclaims In Trade Secrets Suit
• Health Co. Wants To Quit Nicotine Surcharge Suit
• 4 Trends That Will Shape Venture Capital Funding In 2025
• Tech Co., Feds Seek Wins In Commercial Item Preference Row
• Social Media Apps Fail To Trim Calif. Mental Health Mass Tort
• Home Care Co. Must Pay $15M In DOL OT Suit
• Justices To Review ACA Preventive Care Fight
• Updated HIPAA Rule Is A Necessary Step For Data Protection
• Defunct Nursing School Inks $5M Deal To End Consumer Suits
• Off The Bench: Venu Deal Off, Fox Suit, Gender Rules Wobble
• Ex-CEO's Sentencing In COVID Test Securities Fraud Delayed
• Holland & Knight Balks At 'Tactical' DQ Bid In Benefits Fight
• 6 Predictions For Cyber Risk And Insurance In 2025
• Ex-McKinsey Partner Admits To Obstructing Purdue Probe
• Illinois Adds 4 Conditions To Medical Pot Eligibility List
• 7 Ways 2nd Trump Administration May Affect Partner Hiring
• BCLP's Global Healthcare Chair Jumps To Dechert
• Tort Report: Philadelphia Tops Annual 'Judicial Hellhole' List
• IP Forecast: OpenAI, Microsoft Look To Toss NYT Case
• CFPB Hit With 2nd Suit Over Medical Debt Reporting Rule
• Amgen Says Enbrel Protected By Legit Patents, Rulings
• Biden's Title IX Gender Identity Rule Struck By Ky. Judge
• Kroger Accused By Calif. AG Of Ignoring Opioid 'Red Flags'
• Cancer Org Fails To Get Rival's TM Counterclaims Tossed
• Sentara Health Workers Say Retirement Fund Is Mismanaged
• Grieving Parents Urge Court To Discern Fraud From Med Mal
• Ga. Parents Say Daughter 'Disfigured' In Botched Delivery
• New Mexico Justices Say Local Gov'ts Can't Restrict Abortion
• Stem Cell Therapy Co. Hit With $5.1M Deceptive Ad Judgment
• How Trump 2.0 May Change Business In Latin America
• AFL-CIO, SEIU Promise Expanded Power With Reaffiliation
• Courts Must Curb The Drug Price Negotiation Program
• Mass. Hospital, Insurer Settle Pandemic Coverage Row
• E-Discovery Quarterly: Rulings On Custodian Selection
• VITAS Must Face Wiretap Suit Over Customer Service Calls
• Ropes & Gray Reps Valspring Capital On Debut $255M Fund
• AI Startup Anthropic Seeks $60B Valuation, Plus More Rumors
• Yale Wins Info Battle In $435M Hospital Sale Contract Fight
• Ropes & Gray-Led Vistria Wraps Largest-Ever Fund At $3B
• Embryo Loss Suits Against CooperSurgical Mount In Conn.
• Wash. Official Presses Hospital On Filing Delay In Death Suit
• Meta, Microsoft, Google Seek To Toss DNA Data-Sharing Suit
• Captive Insurer Says Reinsurer Must Cover Legionnaires' Row
• Colo. Judge Certifies National Class Of Senior Care Investors
• UnitedHealth Wants $3.3B Amedisys Deal Challenge Tossed
• Patent Board Knocks Out Most Of Apple Patent
• USTR Warns Of Risks Posed By Counterfeit Pharmacies
• Telligen's TM Suit Against IT Co. Can Move Forward
• CFPB Hit With Industry Suit Over Medical Debt Reporting Rule
• 3 Firms Steer Galapagos' Plan To Spin Off New Drug Company
• Indiana Lawmakers File Medical Pot, Decriminalization Bills
• Ariz. Tribe Sues Social Media Giants Over Youth Mental Health
• 2nd Circ. Backs NYC Hospital In Retirement Plan Fee Suit
• Buchanan Ingersoll Adds Frier Levitt Pharmacy Atty In NJ
• The OIG Report: Preparing For Oversight In 2025
• Wilson Sonsini, Cooley Lead $621M Take-Private Of Accolade
• Exercising On My Peloton Bike Makes Me A Better Lawyer
• DOJ Watchdog Criticizes Trump Officials For COVID Leaks
• HHS Fines Mass. Health Firm $80K Over Ransomware Attack
• Alcohol Warnings Unlikely To Bring Same Fate Tobacco Faced
• Feds Defend FCA Whistleblower Constitutionality At 11th Circ.
• Surgeon Says Unprovided Report Should Nix Transplant Suit
• Conn. AG, Feds Reach 3rd Dentist Kickback Settlement
• Cannabis Reformers Move To Oust DEA From Pot Hearings
• Seton Hall COVID Isolation Death Suit Was Too Late, Judge Says
• 5 Argument Sessions Benefits Attys Should Check Out In Jan.
• 6th Circ. Declines To Send Publix Questions To Ga. High Court
• 5 Drug And Device Developments That Shaped 2024
• How To Manage During A Trade Dispute With USMCA Partners
• Judge OKs Dig Into Yale, Fertility Doctor's Decade Of Files
• 4th Circ. Revives Christian Vax Refuser's Religious Bias Suit
• CFPB Adopts Rule To Take Medical Debt Off Credit Reports
• Trump Selects Long Island Judge For EDNY's Top Prosecutor
• Athira Inks $4M FCA Deal Over Ex-CEO's Research Fraud
• Sidley, Wachtell Guide Inari Medical's $4.9B Sale To Stryker
• Medical Debt Suit Against Credit Bureaus Tossed, For Now
• USAA Hits Mich. Clinics, Owners With Billing Fraud Claims
• 'Golden Rule' Claim Doesn't Fly In $7M Med Mal Verdict Appeal
• 'Iron Man 2' Actor Sentenced To Over 8 Years For COVID Scam
• 5th Circ. Iffy On Humana, Blue Cross Allergy Meds Denials
• Labcorp Loses Appeal Of Gene-Testing Patent In $372M Case
• DC Judge Denies Atty's Bid To Hasten Search For DEA Leak
• Judge Rejects Rape Kit Seller's 2nd Bid To Pause Wash. Ban
• Ga. Physician Assistant Sues Insurer Over Disability Benefits
• Indian Chemical Cos. Supplied Fentanyl Precursors, DOJ Says
• Teoxane Outbids Crown With New Revance Therapeutics Bid
• How New Fraud Enforcement Tool Affects Gov't Contractors
• SEC Seeks To Bar Milbank Probe From Dialysis Execs' Trial
• Outpatient Surgery Co. Strikes $1.5M Deal To End 401(k) Suit
• Sheppard Mullin Hires University Of Calif. Health Counsel
• Staffing Co. Strikes $4.4M Deal To End Nurses' Wage Suit
• Exploring Venue Strategy For Trump-Era Regulatory Litigation
• Girard Sharp Launches Into New Year With New Leadership
• Aetna Says Takeda Inked Deal To Block Generics, Keep Profits
• Hospital Org Inks $135M Deal To End Ex-CFO's Fraud Claims
• DOJ Wants Oct. Amedisys Trial, UnitedHealth Wants Aug.
• Mass. Justices Affirm $29M Award In Leg Amputation Suit
• PBMs 'Wasting' Time in Opioid MDL Discovery Spat: Judge
• Outcome Execs Say Ill. Judge Should End Restitution Process
• Lyft, Home Health Agency Sued Over Fatal Crash
• Consultants Should Be Aware Of DOJ's Potential New Reach
• NY Nursing Home Blames AG's 'Crusade' For Ch. 11
• Mich. Justices Asked To Ease Hospital Liability Standard
• Physician Assistant Can't Avoid Suspension For Hiding Probe
• Settlement Reached In Hartford HealthCare Antitrust Suit
• Insurers Ordered To Pay $165M For Deceptive Marketing
• Alcohol Should Have Cancer Warnings, Surgeon General Says
• DC Kept Disabled People In Restrictive Care Too Long: Ruling
• Issa Again Selected To Lead House IP Subcommittee
• 1st Private Co. Joins Insulin Price-Fixing MDL
• Product Safety Issues In 2024 Highlight Need For Vigilance
• Lessons Learned From 2024's Top ADA Decisions
• Ozempic Caused Severe Pain And Hospitalization, Suit Says
• Eli Lilly Slams Suit Alleging Shortage Of Weight-Loss Drug
• Hikma Wants Extension At High Court In Skinny Label Case
• Playing Esports Makes Me A Better Lawyer
• Roche Strikes $80M Oncology Drug Deal With Chinese Biotech
• Aetna Sues Drugmakers In Conn., Alleging Generics Price-Fixing
• Beasley Allen Aims To Toss Suit From Ex-Ally Firm
• IRS, Treasury Float Regs On Excise Taxes For Drugmakers
• Insurer Shorting Autism Provider On Required Care, Suit Says
• Healthcare and Life Science Deals Attys Expect In 2025
• Health Tech Regulatory Trends To Watch In 2025
• An Associate's Guide To Career Development In 2025
• Personal Injury, Medical Malpractice Cases To Watch In 2025
• Bankruptcy Issues To Watch In 2025
• High-Stakes Healthcare Court Battles To Watch In 2025
• Healthcare And Life Science Policies To Watch In 2025
• Product Liability Cases To Watch In 2025
• The Hottest Topics Appellate Attys Are Tracking In 2025
• 2025 Michigan Cases To Watch
• Native American Cases To Watch In 2025
• Patent Cases To Watch In 2025
• Federal Rules Impacted Tribes In 2024, With More To Come
• 5 Policy Changes Benefits Attys Should Watch For In 2025
• Trials To Watch In 2025
• Cannabis And Hemp Lawsuits To Watch In 2025
• Cannabis Advocates Hone Their Policy Goals For 2025
• Pa. Legislation To Watch: Noncompetes, Funding Solutions
• Pa. Cases To Watch In 2025: Climate Change And Skill Games
• NC Cases To Watch In 2025: NASCAR Fight, Healthcare Rows
• Connecticut Cases To Watch In 2025: Ethics, Mergers & Actors